ReviewCancer medicine2020

Testing considerations for phosphatidylinositol-3-kinase catalytic subunit alpha as an emerging biomarker in advanced breast cancer.

Deborah L Toppmeyer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.